IGF1 (insulin like growth factor 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: IGF1 (insulin like growth factor 1) Homo sapiens
Analyze
Symbol: IGF1
Name: insulin like growth factor 1
RGD ID: 70506
HGNC Page HGNC:5464
Description: Enables signaling receptor binding activity. Involved in several processes, including positive regulation of cell population proliferation; positive regulation of macromolecule metabolic process; and positive regulation of signal transduction. Acts upstream of or within cell activation. Located in extracellular space. Part of alphav-beta3 integrin-IGF-1-IGF1R complex and insulin-like growth factor ternary complex. Implicated in several diseases, including acne; brain ischemia; diabetes mellitus (multiple); myopia; and neurodegenerative disease (multiple). Biomarker of several diseases, including Henoch-Schoenlein purpura; artery disease (multiple); autoimmune disease (multiple); bone disease (multiple); and eye disease (multiple).
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: IGF; IGF-I; IGF-IA; IGF-IB; IGF1A; IGFI; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor IA; insulin-like growth factor IB; mechano growth factor; MGF; somatomedin-C
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Is Marker For: QTLs:   BW58_H   BW104_H  
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh3812102,395,874 - 102,481,839 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl12102,395,874 - 102,481,744 (-)EnsemblGRCh38hg38GRCh38
GRCh3712102,789,652 - 102,874,341 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 3612101,313,806 - 101,398,454 (-)NCBINCBI36hg18NCBI36
Build 3412101,292,143 - 101,376,791NCBI
Celera12102,453,601 - 102,538,345 (-)NCBI
Cytogenetic Map12q23.2NCBI
HuRef1299,849,028 - 99,933,911 (-)NCBIHuRef
CHM1_112102,756,305 - 102,841,104 (-)NCBICHM1_1
T2T-CHM13v2.012102,357,015 - 102,441,796 (-)NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
acne  (IDA,IEP)
acoustic neuroma  (IEP)
acromegaly  (EXP)
acute kidney failure  (EXP)
adenoma  (EXP)
Albuminuria  (IAGP)
alcoholic neuropathy  (ISO)
alopecia  (IEP)
Alzheimer's disease  (EXP,IAGP,IDA,IEP,ISO)
arteriosclerosis  (IEP)
autistic disorder  (EXP)
Brain Injuries  (IDA)
brain ischemia  (IMP,ISO)
breast cancer  (ISO)
Breast Neoplasms  (EXP)
Burns  (ISO)
Cachexia  (EXP)
Cardiomegaly  (EXP)
carotid artery disease  (IEP)
Carotid Artery Injuries  (ISO)
Chemical and Drug Induced Liver Injury  (EXP)
cholestasis  (EXP,ISO)
Cockayne syndrome  (ISO)
colitis  (EXP)
congenital diaphragmatic hernia  (ISO)
congenital disorder of glycosylation Ia  (IEP)
congenital hypothyroidism  (ISO)
congestive heart failure  (ISO)
corneal disease  (EXP)
Coronary Disease  (IDA)
coronary stenosis  (ISO)
Crohn's disease  (EXP)
cystic fibrosis  (IEP)
Deafness  (ISO)
demyelinating disease  (EXP)
diabetes mellitus  (IEP)
Diabetic Cardiomyopathies  (EXP)
Diabetic Foot  (IEP)
Diabetic Nephropathies  (IEP,ISO)
diabetic neuropathy  (IEP,ISO)
diabetic retinopathy  (IAGP,IEP)
Diaphragmatic Hernia  (EXP)
dilated cardiomyopathy  (IDA)
Drug-Related Side Effects and Adverse Reactions  (EXP)
Dwarfism  (IMP,ISO)
end stage renal disease  (EXP)
endometriosis  (EXP)
Endotoxemia  (ISO)
Experimental Arthritis  (ISO)
Experimental Autoimmune Encephalomyelitis  (IDA)
Experimental Diabetes Mellitus  (EXP,ISO)
Experimental Liver Cirrhosis  (EXP,IDA,ISO)
familial Mediterranean fever  (IEP)
Female Urogenital Diseases  (EXP)
fetal alcohol spectrum disorder  (ISO)
Fetal Growth Retardation  (IDA,ISO)
Fetal Macrosomia  (IEP)
folic acid deficiency anemia  (ISO)
granulomatosis with polyangiitis  (IEP)
Graves ophthalmopathy  (IEP)
Graves' disease  (IEP)
Growth Disorders  (IAGP)
head and neck squamous cell carcinoma  (EXP)
Head Injuries, Closed  (IEP)
Hearing Loss, Noise-Induced  (IEP)
Henoch-Schoenlein purpura  (IEP)
hepatocellular carcinoma  (EXP)
high grade glioma  (IEP)
Huntington's disease  (IDA,ISO)
Hyperalgesia  (EXP)
Hyperoxia  (IDA)
Hyperphagia  (ISO)
hypertension  (EXP,IEP,ISO)
hypertrophic cardiomyopathy  (IEP)
hypothyroidism  (ISO)
Hypoxia-Ischemia, Brain  (IDA,ISO)
Insulin-Like Growth Factor I Deficiency  (IAGP)
intellectual disability  (IAGP)
Intervertebral Disc Displacement  (ISO)
kidney disease  (EXP)
Knee Osteoarthritis  (IEP,ISO)
Kuhnt-Junius degeneration  (IEP)
Laron syndrome  (IEP)
Malocclusion  (ISO)
Mammary Neoplasms, Experimental  (EXP,ISO)
Metabolic Bone Diseases  (EXP,IDA,ISO)
microcephaly  (IAGP,IMP)
middle cerebral artery infarction  (EXP)
muscular atrophy  (EXP)
myocardial infarction  (IAGP,ISO)
Myocardial Ischemia  (EXP,IEP,ISO)
myopia  (IAGP)
Nasal Polyps  (IEP)
Neointima  (IAGP)
Neoplasm Invasiveness  (EXP)
Neoplasm Metastasis  (EXP,IEP)
Nerve Degeneration  (EXP)
non-alcoholic fatty liver disease  (ISO)
Noonan syndrome  (IEP,ISO)
osteoarthritis  (IEP)
Osteophytes  (ISO)
osteoporosis  (ISO)
Osteoporotic Fractures  (IAGP,IEP,ISO)
Oxygen-Induced Retinopathy  (ISO)
pancreatic cancer  (IAGP)
pancreatic ductal carcinoma  (ISO)
PEHO syndrome  (IEP)
peripheral nervous system disease  (EXP)
Pituitary Neoplasms  (EXP)
Plaque, Atherosclerotic  (IDA)
polycystic ovary syndrome  (IEP)
Postmenopausal Osteoporosis  (IEP)
Precocious Puberty  (EXP)
progeria  (ISO)
prostate carcinoma in situ  (ISO)
Prostatic Neoplasms  (EXP,ISO)
psoriasis  (IEP)
pulmonary fibrosis  (EXP)
pycnodysostosis  (IEP)
Reperfusion Injury  (ISO)
retinopathy of prematurity  (IEP,ISO)
rheumatic heart disease  (IEP)
Rhinosinusitis  (ISO)
Right Ventricular Hypertrophy  (ISO)
Sarcopenia  (IEP)
severe acute respiratory syndrome  (IEP)
Skin Neoplasms  (EXP,IMP)
Skull Fractures  (IEP)
Spontaneous Abortions  (EXP)
Stroke  (IEP,ISO)
Sudden Hearing Loss  (IDA)
Thinness  (IEP)
Tongue Neoplasms  (IEP)
transient cerebral ischemia  (ISO)
Turner syndrome  (IEP)
type 1 diabetes mellitus  (EXP,IDA,IEP)
type 2 diabetes mellitus  (IDA,ISO)
urinary bladder cancer  (EXP)
uveal melanoma  (IEP)
vascular dementia  (IEP,ISO)
Wounds and Injuries  (ISO)
Zinc Deficiency  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-schisandrin B  (ISO)
(-)-anisomycin  (EXP)
(-)-epigallocatechin 3-gallate  (EXP)
(R)-noradrenaline  (ISO)
(S)-nicotine  (ISO)
1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (ISO)
1,1-dichloroethene  (ISO)
1,2,3,4,7,8-Hexachlorodibenzodioxin  (ISO)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
1-methylphenanthrene  (EXP)
17alpha-ethynylestradiol  (EXP,ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (ISO)
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one  (EXP)
17beta-hydroxy-5alpha-androstan-3-one  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (EXP,ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,6-trinitrobenzenesulfonic acid  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (EXP,ISO)
2,4-dinitrotoluene  (ISO)
2-nitrotoluene  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (EXP,ISO)
3H-1,2-dithiole-3-thione  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxynon-2-enal  (ISO)
4-hydroxyphenyl retinamide  (EXP,ISO)
4-nitrophenol  (ISO)
4-tert-Octylphenol  (ISO)
5-fluorouracil  (ISO)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (ISO)
6-propyl-2-thiouracil  (ISO)
7,12-dimethyltetraphene  (ISO)
8-Br-cAMP  (EXP)
9-cis-retinoic acid  (EXP)
acetamide  (ISO)
acrylamide  (ISO)
actinomycin D  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (EXP,ISO)
AICA ribonucleotide  (ISO)
aldehydo-D-glucose  (EXP)
all-trans-4-oxoretinoic acid  (EXP)
all-trans-retinoic acid  (EXP,ISO)
alpha-(methylamino)isobutyric acid  (ISO)
aluminium atom  (EXP)
aluminium oxide  (EXP)
aluminium sulfate (anhydrous)  (EXP)
aluminium(0)  (EXP)
amino acid  (ISO)
amiodarone  (ISO)
ammonium chloride  (ISO)
anandamide  (ISO)
anthra[1,9-cd]pyrazol-6(2H)-one  (EXP)
arsane  (EXP,ISO)
arsenic atom  (EXP,ISO)
arsenite(3-)  (ISO)
arsenous acid  (EXP,ISO)
astemizole  (EXP)
azathioprine  (EXP)
baicalein  (EXP)
belinostat  (EXP)
benzbromarone  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[b]fluoranthene  (EXP)
Benzoyl peroxide  (ISO)
beta-naphthoflavone  (ISO)
bexarotene  (ISO)
bezafibrate  (EXP)
bicalutamide  (EXP)
biochanin A  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bleomycin A2  (ISO)
bosentan  (EXP)
bromobenzene  (ISO)
bromochloroacetic acid  (ISO)
bucladesine  (EXP)
buspirone  (ISO)
Butylbenzyl phthalate  (ISO)
butyric acid  (EXP)
C60 fullerene  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
calcidiol  (ISO)
calcitriol  (EXP)
calcium atom  (ISO)
calcium silicate  (ISO)
calcium(0)  (ISO)
Candesartan cilexetil  (ISO)
cannabidiolic acid  (ISO)
capsaicin  (EXP,ISO)
capsazepine  (ISO)
capsiate  (ISO)
captan  (ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
carmustine  (EXP)
cetrorelix  (EXP)
CGP 52608  (EXP)
chelerythrine  (ISO)
chlormequat chloride  (ISO)
chloroacetic acid  (ISO)
chlorohydrocarbon  (EXP)
chloroprene  (ISO)
chlorpyrifos  (ISO)
cholesterol  (ISO)
chromium atom  (ISO)
chromium(3+) trichloride  (ISO)
chrysin  (ISO)
ciguatoxin CTX1B  (ISO)
cisplatin  (EXP)
clofibrate  (ISO)
clofibric acid  (ISO)
clozapine  (EXP)
cobalt atom  (ISO)
cobalt dichloride  (EXP,ISO)
cobalt(2+) sulfate  (ISO)
colforsin daropate hydrochloride  (EXP)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) chloride  (ISO)
corticosterone  (ISO)
cortisol  (EXP)
coumestrol  (ISO)
crocidolite asbestos  (EXP)
Cuprizon  (ISO)
curcumin  (EXP,ISO)
cycloheximide  (EXP,ISO)
cyclosporin A  (EXP,ISO)
cypermethrin  (ISO)
cyproconazole  (ISO)
cyproterone acetate  (EXP)
D-glucose  (EXP)
D-mannitol  (EXP)
D-penicillamine  (EXP)
dantrolene  (EXP)
DDE  (EXP)
DDT  (EXP,ISO)
deguelin  (EXP)
Deoxycorticosterone acetate  (ISO)
deoxynivalenol  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
diarsenic trioxide  (EXP,ISO)
diazinon  (ISO)
dibenz[a,h]anthracene  (EXP)
dibenziodolium  (EXP)
dibenzo[a,l]pyrene  (EXP)
dibutyl phthalate  (ISO)
dicoumarol  (EXP)
dieldrin  (ISO)
dienogest  (EXP)
diethyl malate  (ISO)
diethyl phthalate  (ISO)
diethylstilbestrol  (ISO)
dihydrocapsaicin  (ISO)
Dimethyl phthalate  (ISO)
dioxygen  (EXP,ISO)
dipentyl phthalate  (ISO)
disodium selenite  (ISO)
diuron  (ISO)
dobutamine  (ISO)
doxorubicin  (EXP,ISO)
enalapril  (ISO)
endosulfan  (ISO)
enzalutamide  (EXP)
epoxiconazole  (ISO)
estriol  (EXP)
ethanol  (EXP,ISO)
ethylene glycol bis(2-aminoethyl)tetraacetic acid  (EXP)
felbamate  (ISO)
fenarimol  (ISO)
fenvalerate  (ISO)
fipronil  (EXP)
flavonoids  (EXP)
flavonol  (EXP)
fluoranthene  (EXP)
flutamide  (EXP,ISO)
fluvastatin  (EXP)
folpet  (ISO)
fulvestrant  (EXP,ISO)
fumonisin B1  (ISO)
furan  (ISO)
furazolidone  (EXP)
furosemide  (ISO)
gabapentin  (ISO)
gadolinium trichloride  (ISO)
gamma-hexachlorocyclohexane  (ISO)
genistein  (EXP,ISO)
ginsenoside Rb1  (ISO)
Ginsenoside Rh4  (ISO)
glucose  (EXP)
glutathione  (ISO)
glyphosate  (EXP)
gold atom  (EXP)
gold(0)  (EXP)
griseofulvin  (ISO)
heptachlor  (ISO)
herbicide  (ISO)
hexachlorobenzene  (EXP,ISO)
hydrogen peroxide  (EXP)
hydroquinone  (EXP)
ibuprofen  (ISO)
icariin  (ISO)
indometacin  (EXP,ISO)
irinotecan  (EXP)
iron atom  (ISO)
iron(0)  (ISO)
isoflavones  (EXP,ISO)
isoflurane  (ISO)
isoprenaline  (ISO)
isotretinoin  (EXP)
L-ascorbic acid 2-phosphate  (EXP)
L-ethionine  (ISO)
L-methionine  (ISO)
lead diacetate  (ISO)
lead(0)  (EXP)
lead(2+)  (EXP)
leflunomide  (ISO)
leuprolide  (EXP)
levonorgestrel  (EXP)
lidocaine  (ISO)
linuron  (ISO)
lipopolysaccharide  (EXP,ISO)
lithium chloride  (ISO)
lornoxicam  (ISO)
lovastatin  (ISO)
LY294002  (EXP,ISO)
lycopene  (EXP,ISO)
maleic acid  (EXP)
maneb  (ISO)
manganese(II) chloride  (ISO)
masoprocol  (EXP)
melatonin  (ISO)
mercury atom  (EXP)
mercury dichloride  (ISO)
mercury(0)  (EXP)
metformin  (EXP,ISO)
methimazole  (EXP,ISO)
methoxychlor  (ISO)
methyl methanesulfonate  (EXP)
methylmercury chloride  (EXP,ISO)
methylseleninic acid  (EXP)
mifepristone  (EXP,ISO)
MK-2206  (ISO)
monodansylcadaverine  (EXP)
monosodium L-glutamate  (ISO)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine  (ISO)
N,N-diethyl-m-toluamide  (EXP)
N-acetyl-L-cysteine  (EXP)
N-methyl-4-phenylpyridinium  (EXP,ISO)
N-methyl-N-nitrosourea  (EXP)
N-nitrosodiethylamine  (ISO)
N-Nitrosopyrrolidine  (EXP)
naphthalene  (ISO)
naringin  (ISO)
nefazodone  (ISO)
nickel atom  (EXP)
nickel dichloride  (EXP)
nicotine  (ISO)
nifedipine  (EXP)
nimesulide  (ISO)
nitrofen  (ISO)
nitroprusside  (EXP,ISO)
nonivamide  (ISO)
Nordihydrocapsaicin  (ISO)
O-methyleugenol  (EXP)
ochratoxin A  (ISO)
octreotide  (EXP)
okadaic acid  (ISO)
omeprazole  (ISO)
Osajin  (EXP)
oxaliplatin  (ISO)
p-menthan-3-ol  (EXP)
p-tert-Amylphenol  (ISO)
para-Cresidine  (ISO)
paracetamol  (EXP,ISO)
paraquat  (ISO)
PCB138  (ISO)
pendimethalin  (ISO)
pentane-2,3-dione  (ISO)
pentetic acid  (ISO)
pentetrazol  (ISO)
perfluorododecanoic acid  (ISO)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (EXP)
perfluorooctanoic acid  (EXP,ISO)
phenacetin  (ISO)
phenobarbital  (EXP,ISO)
phenylarsine oxide  (ISO)
phenylephrine  (ISO)
phenytoin  (ISO)
phorbol 13-acetate 12-myristate  (ISO)
phosphatidylcholine  (ISO)
picolinic acid  (ISO)
picropodophyllotoxin  (ISO)
pioglitazone  (EXP)
pirinixic acid  (ISO)
polaprezinc  (EXP)
poly(I:C)  (ISO)
Pomiferin  (EXP)
potassium atom  (ISO)
potassium chloride  (ISO)
potassium dichromate  (ISO)
prazosin  (ISO)
prednisolone  (EXP)
pregnenolone  (EXP)
pregnenolone 16alpha-carbonitrile  (ISO)
prochloraz  (ISO)
progesterone  (EXP,ISO)
propiconazole  (ISO)
Ptaquiloside  (ISO)
puerarin  (EXP,ISO)
quercetin  (EXP,ISO)
quinidine  (EXP)
raloxifene  (EXP,ISO)
reactive oxygen species  (EXP)
Rebamipide  (ISO)
resveratrol  (EXP,ISO)
rimonabant  (ISO)
rivastigmine  (ISO)
Rosavin  (EXP)
rotenone  (EXP,ISO)
ruthenium red  (EXP)
rutin  (ISO)
SB 203580  (ISO)
serpentine asbestos  (ISO)
shikimic acid  (ISO)
silicon dioxide  (ISO)
silver atom  (ISO)
silver(0)  (ISO)
simvastatin  (ISO)
sirolimus  (EXP,ISO)
sodium arsenate  (ISO)
sodium arsenite  (EXP,ISO)
sodium atom  (ISO)
sodium dichromate  (ISO)
sodium fluoride  (ISO)
Sodium salicylate  (ISO)
sophoraflavanone B  (ISO)
sorafenib  (EXP)
sphingosine 1-phosphate  (EXP)
staurosporine  (ISO)
streptozocin  (ISO)
succimer  (ISO)
superoxide  (EXP)
tacrolimus hydrate  (ISO)
tamoxifen  (EXP,ISO)
tauroursodeoxycholic acid  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP,ISO)
testosterone enanthate  (ISO)
tetrachloromethane  (ISO)
tetradecane  (ISO)
tetramethrin  (ISO)
tetrathiomolybdate(2-)  (EXP)
thalidomide  (EXP)
thimerosal  (EXP,ISO)
thioacetamide  (ISO)
thymidine  (EXP)
thyroxine  (ISO)
Tiron  (EXP)
titanium dioxide  (ISO)
topiramate  (ISO)
topotecan  (ISO)
tremolite asbestos  (ISO)
triadimefon  (ISO)
trichloroethene  (ISO)
trichostatin A  (ISO)
triclosan  (ISO)
trilostane  (EXP)
trimethyltin  (ISO)
triphenyl phosphate  (ISO)
triphenylstannane  (ISO)
Triptolide  (ISO)
troglitazone  (ISO)
tunicamycin  (EXP)
undecane  (ISO)
urethane  (ISO)
valproic acid  (EXP,ISO)
vinclozolin  (ISO)
vincristine  (EXP,ISO)
wortmannin  (EXP,ISO)
zearalenone  (EXP)
zinc atom  (EXP,ISO)
zinc oxide  (ISO)
zinc sulfate  (ISO)
zinc(0)  (EXP,ISO)
zoledronic acid  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
activation of protein kinase B activity  (IMP)
aging  (ISO)
androgen receptor signaling pathway  (ISO)
blood vessel remodeling  (ISO)
bone development  (ISO)
bone mineralization involved in bone maturation  (IDA)
branching morphogenesis of an epithelial tube  (ISO)
cardiac atrium development  (ISO)
cell activation  (IDA)
cell development  (ISO)
cell population proliferation  (IBA,IMP,ISO)
cellular response to amyloid-beta  (IGI)
cellular response to dexamethasone stimulus  (ISO)
cellular response to electrical stimulus  (ISO)
cellular response to estradiol stimulus  (ISO)
cellular response to glucose stimulus  (ISO)
cellular response to insulin stimulus  (ISO)
cellular response to insulin-like growth factor stimulus  (ISO)
cellular response to nicotine  (ISO)
cellular response to progesterone stimulus  (ISO)
cellular response to Thyroglobulin triiodothyronine  (ISO)
cellular response to zinc ion starvation  (ISO)
cerebellar granule cell precursor proliferation  (ISO)
chondroitin sulfate proteoglycan biosynthetic process  (ISO)
circadian rhythm  (ISO)
cranial suture morphogenesis  (ISO)
detection of mechanical stimulus involved in sensory perception  (ISO)
epithelial to mesenchymal transition  (NAS)
ERK1 and ERK2 cascade  (IMP)
exocrine pancreas development  (ISO)
extrinsic apoptotic signaling pathway in absence of ligand  (ISO)
female pregnancy  (ISO)
glial cell differentiation  (ISO)
glycolate metabolic process  (TAS)
inner ear development  (ISO)
insulin-like growth factor receptor signaling pathway  (IBA,IMP,ISO)
lung alveolus development  (ISO)
lung development  (ISO)
lung lobe morphogenesis  (ISO)
lung vasculature development  (ISO)
mammary gland development  (ISO)
memory  (ISO)
multicellular organism growth  (ISO)
muscle hypertrophy  (IMP)
muscle organ development  (TAS)
myoblast differentiation  (IDA)
myoblast proliferation  (IDA)
myotube cell development  (IDA)
negative regulation of amyloid-beta formation  (IGI)
negative regulation of androgen receptor signaling pathway  (ISO)
negative regulation of apoptotic process  (IBA,IMP,ISO)
negative regulation of cell population proliferation  (ISO)
negative regulation of cholangiocyte apoptotic process  (ISO)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process  (ISO)
negative regulation of ERK1 and ERK2 cascade  (ISO)
negative regulation of extrinsic apoptotic signaling pathway  (IDA)
negative regulation of gene expression  (IDA)
negative regulation of immune system process  (ISO)
negative regulation of interleukin-1 beta production  (IGI)
negative regulation of muscle cell apoptotic process  (ISO)
negative regulation of neuroinflammatory response  (IGI)
negative regulation of neuron death  (ISO)
negative regulation of oligodendrocyte apoptotic process  (ISO)
negative regulation of oocyte development  (IMP)
negative regulation of peptidyl-tyrosine phosphorylation  (ISO)
negative regulation of release of cytochrome c from mitochondria  (ISS)
negative regulation of smooth muscle cell apoptotic process  (IDA)
negative regulation of tumor necrosis factor production  (IGI)
negative regulation of vascular associated smooth muscle cell apoptotic process  (IMP)
nervous system development  (ISO)
osteoblast differentiation  (ISO)
phosphatidylinositol 3-kinase signaling  (IMP,ISO)
phosphatidylinositol-mediated signaling  (IDA)
positive regulation of activated T cell proliferation  (IDA)
positive regulation of blood vessel endothelial cell migration  (ISO)
positive regulation of calcineurin-NFAT signaling cascade  (IDA)
positive regulation of cardiac muscle hypertrophy  (IDA,IMP)
positive regulation of cell growth  (ISO)
positive regulation of cell growth involved in cardiac muscle cell development  (IDA,IGI)
positive regulation of cell migration  (IMP)
positive regulation of cell population proliferation  (IBA,IDA,IMP)
positive regulation of cerebellar granule cell precursor proliferation  (ISO)
positive regulation of DNA binding  (IDA)
positive regulation of DNA-templated transcription  (IDA,IMP)
positive regulation of epithelial cell proliferation  (IDA)
positive regulation of ERK1 and ERK2 cascade  (IMP)
positive regulation of fat cell differentiation  (ISO)
positive regulation of fibroblast proliferation  (IDA)
positive regulation of gene expression  (IGI)
positive regulation of glial cell proliferation  (ISO)
positive regulation of glucose import  (IDA)
positive regulation of glycogen biosynthetic process  (IDA)
positive regulation of glycolytic process  (IDA)
positive regulation of glycoprotein biosynthetic process  (IMP)
positive regulation of insulin-like growth factor receptor signaling pathway  (IDA)
positive regulation of MAPK cascade  (IDA)
positive regulation of mitotic nuclear division  (IDA)
positive regulation of myelination  (ISO)
positive regulation of myoblast proliferation  (ISO)
positive regulation of osteoblast differentiation  (IDA,ISO)
positive regulation of peptidyl-tyrosine phosphorylation  (IDA)
positive regulation of phosphatidylinositol 3-kinase signaling  (IBA,IDA,ISO)
positive regulation of protein kinase B signaling  (ISO,NAS)
positive regulation of protein secretion  (IMP)
positive regulation of protein serine/threonine kinase activity  (ISO)
positive regulation of Ras protein signal transduction  (IDA)
positive regulation of smooth muscle cell migration  (IDA)
positive regulation of smooth muscle cell proliferation  (IDA)
positive regulation of steroid hormone biosynthetic process  (ISO)
positive regulation of transcription by RNA polymerase II  (IDA,ISO)
positive regulation of transcription regulatory region DNA binding  (IDA)
positive regulation of trophectodermal cell proliferation  (IMP)
positive regulation of type B pancreatic cell proliferation  (ISO)
positive regulation of tyrosine phosphorylation of STAT protein  (IDA)
positive regulation of vascular associated smooth muscle cell proliferation  (IMP)
positive regulation of vascular endothelial cell proliferation  (ISO)
postsynaptic modulation of chemical synaptic transmission  (ISO)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis  (ISO)
prostate gland epithelium morphogenesis  (ISO)
prostate gland growth  (ISO)
prostate gland stromal morphogenesis  (ISO)
protein kinase B signaling  (IMP)
protein stabilization  (IMP)
proteoglycan biosynthetic process  (IDA,IMP)
Ras protein signal transduction  (TAS)
regulation of calcium ion transport  (ISO)
regulation of cell population proliferation  (ISO)
regulation of establishment or maintenance of cell polarity  (ISO)
regulation of gene expression  (IMP)
regulation of multicellular organism growth  (IEP)
regulation of nitric oxide biosynthetic process  (ISO)
regulation of protein metabolic process  (ISO)
regulation of protein phosphorylation  (IBA,ISO)
regulation of translation  (ISO)
response to activity  (ISO)
response to caffeine  (ISO)
response to epidermal growth factor  (ISO)
response to estradiol  (ISO)
response to ethanol  (ISO)
response to glucocorticoid  (ISO)
response to growth hormone  (ISO)
response to heat  (IDA)
response to hypoxia  (ISO)
response to lipopolysaccharide  (ISO)
response to mechanical stimulus  (ISO)
response to nicotine  (ISO)
response to nutrient  (ISO)
response to nutrient levels  (ISO)
response to organic cyclic compound  (ISO)
response to organic substance  (ISO)
response to starvation  (ISO)
response to steroid hormone  (ISO)
response to thyroid hormone  (ISO)
signal transduction  (IEA,TAS)
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration  (IDA)
skeletal system development  (TAS)
type B pancreatic cell proliferation  (ISO)
type I pneumocyte differentiation  (ISO)
type II pneumocyte differentiation  (ISO)
water homeostasis  (ISO)
wound healing  (IDA)

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Abnormal facial shape  (IAGP)
Abnormality of femur morphology  (IAGP)
Abnormality of metabolism/homeostasis  (IAGP)
Aortic stiffness  (IAGP)
Attention deficit hyperactivity disorder  (IAGP)
Autosomal recessive inheritance  (IAGP)
Bilateral sensorineural hearing impairment  (IAGP)
Cafe-au-lait spot  (IAGP)
Clinodactyly  (IAGP)
Clinodactyly of the 5th finger  (IAGP)
Concave nasal ridge  (IAGP)
Congenital bilateral ptosis  (IAGP)
Congenital onset  (IAGP)
Congenital sensorineural hearing impairment  (IAGP)
Decreased body weight  (IAGP)
Delayed eruption of teeth  (IAGP)
Delayed skeletal maturation  (IAGP)
Failure to thrive  (IAGP)
Hyperactivity  (IAGP)
Hypoglycemia  (IAGP)
Hypogonadism  (IAGP)
Increased susceptibility to fractures  (IAGP)
Insulin resistance  (IAGP)
Intellectual disability  (IAGP)
Intellectual disability, mild  (IAGP)
Intrauterine growth retardation  (IAGP)
Low anterior hairline  (IAGP)
Low posterior hairline  (IAGP)
Microcephaly  (IAGP)
Micrognathia  (IAGP)
Motor delay  (IAGP)
Myopia  (IAGP)
Neonatal hyperbilirubinemia  (IAGP)
Osteopenia  (IAGP)
Osteoporosis  (IAGP)
Prelingual sensorineural hearing impairment  (IAGP)
Prominent forehead  (IAGP)
Ptosis  (IAGP)
Radial deviation of finger  (IAGP)
Reduced bone mineral density  (IAGP)
Sensorineural hearing impairment  (IAGP)
Severe intrauterine growth retardation  (IAGP)
Severe postnatal growth retardation  (IAGP)
Short attention span  (IAGP)
Short stature  (IAGP)
Single transverse palmar crease  (IAGP)
Small for gestational age  (IAGP)
Small placenta  (IAGP)
Truncal obesity  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Abd El Aal DE, etal., Eur J Obstet Gynecol Reprod Biol. 2005 Feb 1;118(2):219-24.
2. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. Aizawa H and Niimura M, J Dermatol. 1995 Apr;22(4):249-52.
3. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. Alvaro D, etal., J Hepatol. 2005 Nov;43(5):875-83. Epub 2005 May 31.
4. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Asthana S, etal., Psychoneuroendocrinology. 1999 Aug;24(6):657-77.
5. Circulating levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury. Beeton CA, etal., J Bone Joint Surg Br. 2002 Apr;84(3):434-9.
6. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. Ben-Amitai D and Laron Z, J Eur Acad Dermatol Venereol. 2011 Aug;25(8):950-4. doi: 10.1111/j.1468-3083.2010.03896.x. Epub 2010 Nov 4.
7. Changes in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemia. Beresewicz M, etal., Int J Dev Neurosci. 2010 Feb;28(1):91-7. doi: 10.1016/j.ijdevneu.2009.09.002. Epub 2009 Sep 18.
8. Growth hormone treatment prevents osteoporosis in uremic rats. Berger I, etal., Histol Histopathol. 2007 Nov;22(11):1231-9.
9. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Bhatavdekar JM, etal., Tumour Biol. 1993;14(1):55-8.
10. Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus. Bjarnegard N, etal., Diab Vasc Dis Res. 2009 Jan;6(1):25-31.
11. No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis. Bjorntorp E, etal., J Invest Dermatol. 1997 Nov;109(5):661-5.
12. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. Blakytny R, etal., J Pathol. 2000 Apr;190(5):589-94.
13. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Bol DK, etal., Oncogene. 1997 Apr 10;14(14):1725-34.
14. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. Bondanelli M, etal., J Clin Endocrinol Metab. 2006 Oct;91(10):3928-34. Epub 2006 Aug 1.
15. Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production. Bouillon R Verh K Acad Geneeskd Belg. 1992;54(4):365-91; discussion 391-2.
16. Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes. Calderari S, etal., Diabetologia. 2007 Jul;50(7):1463-71. Epub 2007 May 3.
17. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes. Capoluongo E, etal., Cytokine. 2006 Jun;34(5-6):303-11. Epub 2006 Aug 2.
18. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications. Capoluongo E, etal., Eur Cytokine Netw. 2006 Sep;17(3):167-74.
19. Differentially expressed angiogenic genes in diabetic erectile tissue - results from a microarray screening. Castela A, etal., Mol Genet Metab. 2012 Feb;105(2):255-62. doi: 10.1016/j.ymgme.2011.11.002. Epub 2011 Nov 10.
20. Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic postmenopausal women. Celiker R and Arslan S, Rheumatol Int. 2000;19(6):205-8.
21. Comparative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls. Cha DM, etal., Invest Ophthalmol Vis Sci. 2013 Oct 25;54(10):7038-44. doi: 10.1167/iovs.13-12730.
22. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Chambers MG, etal., Osteoarthritis Cartilage. 1997 Sep;5(5):301-8.
23. Intracellular insulin-like growth factor-1 induces Bcl-2 expression in airway epithelial cells. Chand HS, etal., J Immunol. 2012 May 1;188(9):4581-9. doi: 10.4049/jimmunol.1102673. Epub 2012 Mar 28.
24. Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura. Chen T, etal., Rheumatol Int. 2011 Mar;31(3):321-6. doi: 10.1007/s00296-009-1254-3. Epub 2009 Dec 16.
25. Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy. Chu Q, etal., Mol Ther. 2008 Aug;16(8):1400-8. doi: 10.1038/mt.2008.115. Epub 2008 Jun 10.
26. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. Clemmons DR, etal., Growth Horm IGF Res. 2005 Aug;15(4):265-74.
27. Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy. Coleman RJ, etal., Pediatr Res. 2008 Jul;64(1):50-5. doi: 10.1203/PDR.0b013e31817307ac.
28. Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice. Corrochano S, etal., PLoS One. 2014 Aug 20;9(8):e105595. doi: 10.1371/journal.pone.0105595. eCollection 2014.
29. Preconditioning and post-treatment with cobalt chloride in rat model of perinatal hypoxic-ischemic encephalopathy. Dai Y, etal., Brain Dev. 2014 Mar;36(3):228-40. doi: 10.1016/j.braindev.2013.04.007. Epub 2013 May 18.
30. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Davis ME, etal., Proc Natl Acad Sci U S A. 2006 May 23;103(21):8155-60. Epub 2006 May 12.
31. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. De Rocca Serra-Nedelec A, etal., Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4257-62. doi: 10.1073/pnas.1119803109. Epub 2012 Feb 27.
32. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. Denko CW, etal., J Rheumatol. 1990 Sep;17(9):1217-21.
33. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Duan C and Xu Q, Gen Comp Endocrinol. 2005 May 15;142(1-2):44-52. Epub 2005 Feb 5.
34. Effects of chronic growth hormone and insulin-like growth factor 1 deficiency on osteoarthritis severity in rat knee joints. Ekenstedt KJ, etal., Arthritis Rheum. 2006 Dec;54(12):3850-8.
35. Insulin-like growth factor-1 in psoriatic plaques treated with PUVA and methotrexate. El-Komy M, etal., J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1288-94. doi: 10.1111/j.1468-3083.2010.03966.x. Epub 2011 Jan 17.
36. Insulin growth factor-1 protects against excitotoxicity in the rat striatum. Escartin C, etal., Neuroreport. 2004 Oct 5;15(14):2251-4.
37. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Fath KA, etal., Circ Res. 1993 Feb;72(2):271-7.
38. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Fischer F, etal., Clin Endocrinol (Oxf). 2004 Nov;61(5):595-602.
39. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans. Frenkel S, etal., Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):490-3. doi: 10.1167/iovs.12-10228.
40. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Garnero P, etal., Lancet. 2000 Mar 11;355(9207):898-9.
41. Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury. Gatto M, etal., Lab Invest. 2008 Sep;88(9):986-94. doi: 10.1038/labinvest.2008.63. Epub 2008 Jul 7.
42. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
43. Growth factors and glucose homeostasis in diabetic rats: effects of exercise training. Gomes RJ, etal., Cell Biochem Funct. 2009 Apr 20.
44. Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementia. Gong X, etal., Neurosci Lett. 2012 Mar 28;513(1):20-4. doi: 10.1016/j.neulet.2012.01.077. Epub 2012 Feb 10.
45. Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. Gravholt CH, etal., Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E308-14.
46. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Gravholt CH, etal., Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):332-9. Epub 2006 Oct 25.
47. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Guan J, etal., Neuroscience. 2001;105(2):299-306.
48. Periconceptional alcohol consumption causes fetal growth restriction and increases glycogen accumulation in the late gestation rat placenta. Gårdebjer EM, etal., Placenta. 2014 Jan;35(1):50-7. doi: 10.1016/j.placenta.2013.10.008. Epub 2013 Nov 5.
49. The influence of gestational zinc deficiency on the fetal insulin-like growth factor axis in the rat. Hanna LA, etal., Exp Biol Med (Maywood). 2010 Feb;235(2):206-14. doi: 10.1258/ebm.2009.009018.
50. Immunohistochemical demonstration of insulin-like growth factor I in inflammatory lesions in Wegener's granulomatosis and idiopathic midline destructive disease. Hansson HA, etal., Scand J Rheumatol. 1989;18(3):133-41.
51. Effects of recombinant human growth hormone (r-hGH) on experimental osteoporotic fracture healing. Hao Y, etal., Chin J Traumatol. 2001 May;4(2):102-5.
52. Characterization of SV-40 Tag rats as a model to study prostate cancer. Harper CE, etal., BMC Cancer. 2009 Jan 26;9:30.
53. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Hie M, etal., Int J Mol Med. 2011 Sep;28(3):455-62. doi: 10.3892/ijmm.2011.697. Epub 2011 May 11.
54. MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1. Hu YK, etal., Neurosci Bull. 2013 Dec;29(6):745-51.